The cancer diagnostics company is hours away from losing funding for its tests through the US Medicare system.
Shares in the company have doubled on the ASX over the past year on hopes for the Bendigo-Ophir gold project.
Analysts say company claims of benefits to Vista and its customers from migration to the cloud bear out, even if it will take longer for all of them to get on board.
Telematics company signs its largest Australasian customer with deal for up to 11,000 vehicles.
The horticulture company’s share price raised questions at the annual meeting.
The NZX-listed milk processor faces receivership if special meeting vote does not approve $130m shareholder loan from Bright Dairy.
Casino operator says it bought the stake for $40m in 2022 but is now not ‘strategically necessary’.
The NZX-listed retailer is taking 'decisive action internally'.
The scale of Kathmandu's sales decline through the winter trading period is surprising, analyst says.
Interests linked to Morrison chair Rob Morrison tip over the 5% disclosure threshold.